title: [Heparin and lipoprotein(a). Observations during hemodialysis].
abstract: The effect of heparin (bolus e.v. 5.000 I.U.) on blood levels of Lp(a) and other lipids (triglycerides, -HDL, -LDL and total cholesterol, apo A1, apo B100 and apo A1/apo B100) was studied in 15 patients (8 M and 7 F) with chronic renal failure during hemodialysis. Statistically significant reductions of the basal values were found for Lp(a) and the other lipids in the blood taken before the beginning of dialysis, 30 min' after the heparin bolus. The analysis of third blood sample (at the end of the hemodialysis, one hour after the end of the heparin maintenance infusion) showed a rise of HDL and LDL-lipoproteins over the basal values clearly in relation to reduced heparin and plasmatic fraction of the blood. The values of Lp(a) had not so high increase as consequence of more elevated affinity with heparin and of a possible enhanced metabolic rate via lipoprotein lipase. The authors, in agreement with similar changes of Lp(a) and other lipids previously observed in patients with coronary diseases during bypass surgery in extracorporeal circulation or angioplasty, (interventions requiring generous heparin treatment), believe to have now sufficient data for attributing heparin a causal role for the above mentioned effects. The authors stress the needing of other studies better understand the action to mechanisms of heparin and to evaluate possible future clinical applications of this new interesting Lp(a)-clearing effect.
authors.affiliation: Servizio di Cardiologia A. Cesalpino, Ospedale San Camillo, Roma.
authors.forename: P
authors.initials: P
authors.lastname: Salvini
authors.forename: E
authors.initials: E
authors.lastname: Maddaloni
authors.forename: M V
authors.initials: MV
authors.lastname: Levi della Vida
authors.forename: A
authors.initials: A
authors.lastname: Parma
authors.forename: M G
authors.initials: MG
authors.lastname: Corpetti
authors.forename: M
authors.initials: M
authors.lastname: Di Lorenzo
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D002784:Cholesterol / Q000097:blood; D005260:Female; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000453:epidemiology / Q000628:therapy; D017270:Lipoprotein(a) / Q000097:blood / Q000187:drug effects*; D008074:Lipoproteins / Q000097:blood / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000706:statistics & numerical data; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
chemical_list: D017270:Lipoprotein(a); D008074:Lipoproteins; D014280:Triglycerides; D006493:Heparin; D002784:Cholesterol
vernacular_title: Eparina e lipoproteina(a). Osservazioni in corso di emodialisi.